Genprex (GNPX) vs Alaunos Therapeutics (TCRT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Alaunos Therapeutics is the larger company by market cap ($2.3 million vs $2.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GNPX | TCRT |
|---|---|---|
| Share price | $2.84 | $0.8021 |
| Market cap | $2.33M | $2.35M |
| 1-day change | +3.27% | +2.70% |
| EPS (TTM) | $-9.35 | $-1.76 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1,210.00 | $4.50 |
| 52-week low | $2.53 | $0.72 |
| Distance from 52-week high | -99.77% | -82.18% |
| Average volume | 247.06K | 797.20K |
| Shares outstanding | 819.71K | 2.93M |
| Employees | 13 | 1 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Genprex
GNPX stock →Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes.
Health Care · Biotechnology: Pharmaceutical Preparations · 13 employees
About Alaunos Therapeutics
TCRT stock →Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs.
Health Care · Biotechnology: Pharmaceutical Preparations · 1 employees
GNPX vs TCRT FAQ
Which is bigger, Genprex or Alaunos Therapeutics?
Alaunos Therapeutics (TCRT) is larger, with a market capitalization of $2.35M compared with $2.33M for Genprex (GNPX).
Are Genprex and Alaunos Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.